These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8224659)

  • 21. Spatial approximation between two residues in the mid-region of secretin and the amino terminus of its receptor. Incorporation of seven sets of such constraints into a three-dimensional model of the agonist-bound secretin receptor.
    Dong M; Li Z; Zang M; Pinon DI; Lybrand TP; Miller LJ
    J Biol Chem; 2003 Nov; 278(48):48300-12. PubMed ID: 14500709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholecystokinin downregulates receptors for vasoactive intestinal peptide and secretin in rat pancreatic acini.
    Katsushima S; Adachi H; Honda T; Sato S; Kusui T; Onishi S; Aoki E; Noguchi M; Konishi J
    Am J Physiol; 1990 Mar; 258(3 Pt 1):G395-403. PubMed ID: 2156442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluorescence resonance energy transfer analysis of secretin docking to its receptor: mapping distances between residues distributed throughout the ligand pharmacophore and distinct receptor residues.
    Harikumar KG; Lam PC; Dong M; Sexton PM; Abagyan R; Miller LJ
    J Biol Chem; 2007 Nov; 282(45):32834-43. PubMed ID: 17827151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of two pairs of spatially approximated residues within the carboxyl terminus of secretin and its receptor.
    Dong M; Asmann YW; Zang M; Pinon DI; Miller LJ
    J Biol Chem; 2000 Aug; 275(34):26032-9. PubMed ID: 10859300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [D-Phe4]peptide histidine-isoleucinamide ([D-Phe4]PHI), a highly selective vasoactive-intestinal-peptide (VIP) agonist, discriminates VIP-preferring from secretin-preferring receptors in rat pancreatic membranes.
    Robberecht P; Coy DH; De Neef P; Camus JC; Cauvin A; Waelbroeck M; Christophe J
    Eur J Biochem; 1987 Jun; 165(2):243-9. PubMed ID: 3036504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of peptides related to VIP and secretin with guinea pig pancreatic acini.
    Zhou ZC; Gardner JD; Jensen RT
    Am J Physiol; 1989 Feb; 256(2 Pt 1):G283-90. PubMed ID: 2465694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specific secretin binding sites in rat pancreas.
    Okumura K; Iwakawa S; Inui K; Hori R
    Biochem Pharmacol; 1983 Sep; 32(18):2689-95. PubMed ID: 6313006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Agonist-stimulated phosphorylation of the carboxyl-terminal tail of the secretin receptor.
    Ozcelebi F; Holtmann MH; Rentsch RU; Rao R; Miller LJ
    Mol Pharmacol; 1995 Nov; 48(5):818-24. PubMed ID: 7476911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vasoactive intestinal peptide receptors in pancreas and liver. Structure-function relationship.
    Christophe J; Svoboda M; Waelbroeck M; Winand J; Robberecht P
    Ann N Y Acad Sci; 1988; 527():238-56. PubMed ID: 2839079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of amino acid residues at positions 8-15 of secretin with the N-terminal domain of the secretin receptor.
    Gourlet P; Vilardaga JP; De Neef P; Vandermeers A; Waelbroeck M; Bollen A; Robberecht P
    Eur J Biochem; 1996 Jul; 239(2):349-55. PubMed ID: 8706739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular cloning and expression of a human secretin receptor.
    Patel DR; Kong Y; Sreedharan SP
    Mol Pharmacol; 1995 Mar; 47(3):467-73. PubMed ID: 7700244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular basis and species specificity of high affinity binding of vasoactive intestinal polypeptide by the rat secretin receptor.
    Holtmann MH; Hadac EM; Ulrich CD; Miller LJ
    J Pharmacol Exp Ther; 1996 Nov; 279(2):555-60. PubMed ID: 8930157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular approximations between residues 21 and 23 of secretin and its receptor: development of a model for peptide docking with the amino terminus of the secretin receptor.
    Dong M; Lam PC; Gao F; Hosohata K; Pinon DI; Sexton PM; Abagyan R; Miller LJ
    Mol Pharmacol; 2007 Aug; 72(2):280-90. PubMed ID: 17475809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a biologically active secretin analogue incorporating a radioiodinatable photolabile p-(4-hydroxybenzoyl)phenylalanine in position 10.
    Dong M; Pinon DI; Miller LJ
    Regul Pept; 2002 Nov; 109(1-3):181-7. PubMed ID: 12409231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of photoaffinity labeling to understand the molecular basis of ligand binding to the secretin receptor.
    Dong M; Miller LJ
    Ann N Y Acad Sci; 2006 Jul; 1070():248-64. PubMed ID: 16888175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insights into the structure and molecular basis of ligand docking to the G protein-coupled secretin receptor using charge-modified amino-terminal agonist probes.
    Dong M; Pinon DI; Miller LJ
    Mol Endocrinol; 2005 Jul; 19(7):1821-36. PubMed ID: 15731172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro inhibitory effect of somatostatin on secretin action in exocrine pancreas of rats.
    Matsushita K; Okabayashi Y; Hasegawa H; Koide M; Kido Y; Okutani T; Sugimoto Y; Kasuga M
    Gastroenterology; 1993 Apr; 104(4):1146-52. PubMed ID: 7681794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction among four residues distributed through the secretin pharmacophore and a focused region of the secretin receptor amino terminus.
    Dong M; Zang M; Pinon DI; Li Z; Lybrand TP; Miller LJ
    Mol Endocrinol; 2002 Nov; 16(11):2490-501. PubMed ID: 12403838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sequences (103-110) and (116-120) of the rat secretin receptor are implicated in secretin and VIP recognition.
    Robberecht P; Di Paolo E; Moguilevsky N; Bollen A; Waelbroeck M
    Ann N Y Acad Sci; 2000; 921():362-5. PubMed ID: 11193853
    [No Abstract]   [Full Text] [Related]  

  • 40. Cross-chimeric analysis of selectivity of secretin and VPAC(1) receptor activation.
    Park CG; Ganguli SC; Pinon DI; Hadac EM; Miller LJ
    J Pharmacol Exp Ther; 2000 Nov; 295(2):682-8. PubMed ID: 11046106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.